QoL COVID HBOTNCT06159309
Quality of Life After Hyperbaric Oxygen Therapy in Post-COVID Patients
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Stopped Trial status changed: Active, Not Recruiting → Withdrawn Sponsor's reason: No funding secured to start study Show 5 more changesShow less
- Enrollment target: estimated 200 to confirmed 0
- Eligibility criteria expanded, about 4 words
- Primary completion pushed from Jun 2025 to Dec 2025
- Study completion pushed from Aug 2025 to Feb 2026
- Study description shortened, about 15 words
Notable Primary completion date: Feb 2024 to Jun 2025v3 Show 4 more changesShow less
- Trial status: Recruiting to Active, Not Recruiting
- Study completion date: Aug 2024 to Aug 2025
- Site details revised at 6 of 6 sites
- Collaborators shortened, about 2 words
- Notable Primary endpoint revised
- Study sites: 2 to 6
- Secondary endpoints revised (5)
- Study First Submitted
- Stopped: terminated, suspended or withdrawn
- Notable: the plan changed
Endpoints
Primary
Quality of life 3 and 12 months
Timeframe: 3 and 12 months
Secondary (5)
Long Covid symptoms
Cognitive complaints
Work
Risk factors quality of life
Profile of non-responders versus responders
Arms and interventions
Long Covid patients
All post-COVID patients that are referred for hyperbaric oxygen (and that are eligible for treatment)
Other: Hyperbaric oxygen therapy
Sites
6 sites in 1 country